Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis

Recruiting now · Not applicable

Conditions studied: Suspected Sarcoidosis

In brief

This randomized pilot clinical trial aims to examine whether sample collection with Franseen-type needles are effective for the diagnosis of sarcoidosis, as defined by improved sample quality for pathological diagnosis compared to the conventional Menghini-type needle.

Key facts

Study ID

NCT06220526

Run by

University Health Network, Toronto

People needed

128

Starts

2023-08-18

Expected to finish

2027-02-28

Last updated by the study team

2026-05-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• -Any adult patient aged 18 years or older with enlarged mediastinal and/or hilar lymph nodes
• (≥10 mm short-axis diameter on a CT scan), suspected as having sarcoidosis based on clinical
• history, physical exam, and other investigations, and booked for EBUS-TBNA.

You may not qualify if…

• -Patients that are unable to provide informed consent
• Patients with lymphadenopathy strongly suspected to be secondary to other diseases based on
• clinical history, physical exam, and/or other investigations (e.g., lung cancer, lymphoma,
• infection).

Where it is running

• Toronto General Hospital — Toronto, Ontario, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.